Sweet syndrome after the first dose of SARS-CoV-2 vaccine (Pfizer-BioNTech)

Dermatol Ther. 2022 Dec;35(12):e15915. doi: 10.1111/dth.15915. Epub 2022 Oct 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2
  • Sweet Syndrome* / diagnosis
  • Sweet Syndrome* / etiology

Substances

  • COVID-19 Vaccines